Related Experiment Videos
Medication use patterns after gastric bypass surgery for weight management
Margaret Malone1, Sharon A Alger-Mayer
1Department of Pharmacy Practice, Albany College of Pharmacy, Albany, NY 12208-3492, USA. malonem@acp.edu
The Annals of Pharmacotherapy
|March 3, 2005
Summary
Bariatric surgery effectively reduces medications for obesity-related conditions like diabetes and hypertension. However, the overall number of drugs and supplements may not significantly decrease, particularly in the first year post-gastric bypass.
Area of Science:
- Metabolic and Bariatric Surgery
- Pharmacology
- Clinical Medicine
Background:
- Bariatric surgery, such as gastric bypass, is a proven method for significant weight loss in individuals with a body mass index (BMI) over 40 kg/m².
- Limited research exists on medication usage trends following bariatric surgical procedures.
Purpose of the Study:
- To prospectively track and analyze changes in medication consumption patterns over a two-year period in patients who underwent gastric bypass surgery.
Main Methods:
- A prospective longitudinal study involving adult patients scheduled for gastric bypass.
- Data collection included clinical and demographic information, obesity-related comorbidities, and pre- and post-operative medication and supplement use via medical chart review.
Main Results:
- The study included 114 patients (87% female), with an average age of 45 years.
- Significant reductions in drug therapy for diabetes and hypertension were observed (p < 0.05).
- All patients required postoperative nutritional supplements and surgery-related medications.
Conclusions:
- Gastric bypass surgery demonstrates a positive impact by reducing medications linked to obesity-related comorbidities.
- Despite improvements in comorbidity-specific drug use, the overall intake of medications and supplements shows limited reduction, especially within the first postoperative year.